Frontiers in Immunology (Jan 2022)

Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study

  • Thais G. Moreira,
  • Kimble T. F. Matos,
  • Giovana S. De Paula,
  • Thais M. M. Santana,
  • Raquel G. Da Mata,
  • Fernando C. Pansera,
  • Andre S. Cortina,
  • Marcelle G. Spinola,
  • Clare M. Baecher-Allan,
  • Gerson D. Keppeke,
  • Jules Jacob,
  • Vaseem Palejwala,
  • Karen Chen,
  • Saef Izzy,
  • Brian C. Healey,
  • Rafael M. Rezende,
  • Rogerio A. Dedivitis,
  • Kunwar Shailubhai,
  • Howard L. Weiner

DOI
https://doi.org/10.3389/fimmu.2021.815812
Journal volume & issue
Vol. 12

Abstract

Read online

No abstracts available.

Keywords